AstraZeneca to resume coronavirus vaccine trial after reported side-effect
By Market Watch / September 20, 2012 / marketsanity.com / Article Link
"The independent review process has concluded and following the recommendations of both the independent safety review committee and the U.K. regulator, the MHRA, the trials will recommence in the U.K.,"